MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will present an update of the company’s human embryonic stem cell development programs at 12:00 p.m. ET on Wednesday, November 12, 2008, at the Rodman & Renshaw Annual Global Investment Conference in New York City.
